Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.com
XCancer® has the experts and the experience to provide your center with the backbone, tools, strategies, and business models to make you successful at both. XCancer® is a community cancer center with a solo medical oncologist that has developed a leading radiopharmaceutical clinical trials program recognized globally. Using its experience and processes, XCancer® has successfully guided community cancer centers across the United States with developing highly efficient and quality clinical trial programs.
Start your program today:
Distinguished Investigator
A Distinguished Investigator of Theranostics is a level of distinction conferred upon an individual physician who has demonstrated a mastery of conducting novel radioligand therapies and molecular imaging clinical trials.
RADIOLIGAND THERAPY (RLT) is a highly effective approach to very accurately locating cancer cells and effectively killing those same cells by delivery various radioisotopes to a specific target that is located on a type of cancer. Some of the Radioisotopes are diagnostic for locating cancers & some therapeutic to treat the cancers.
There are several Components to a RLT that are simply demonstrated in the truck diagram including:
To learn more about the specific components being studied today on clinical trials around the world check out the RLT COMPONENTS Tab.
View All
Help us improve your experience